1. Siegel RL, Miller KD, Fuchs HE, Jemal A: Cancer Statistics, 2021. CA: a cancer journal for clinicians 2021, 71(1):7-33.
2. Cocco S, Leone A, Piezzo M, Caputo R, Di Lauro V, Di Rella F, Fusco G, Capozzi M, Gioia GD, Budillon A et al: Targeting Autophagy in Breast Cancer. International journal of molecular sciences 2020, 21(21).
3. Rossi L, Mazzara C, Pagani O: Diagnosis and Treatment of Breast Cancer in Young Women. Current treatment options in oncology 2019, 20(12):86.
4. Pondé NF, Zardavas D, Piccart M: Progress in adjuvant systemic therapy for breast cancer. Nature reviews Clinical oncology 2019, 16(1):27-44.
5. Akram M, Siddiqui SA: Breast cancer management: past, present and evolving. Indian journal of cancer 2012, 49(3):277-282.
6. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA: a cancer journal for clinicians 2019, 69(6):438-451.
7. Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T et al: LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates. Cancer research 2018, 78(14):4059-4072.
8. Demetri GD, Luke JJ, Hollebecque A, Powderly JD, 2nd, Spira AI, Subbiah V, Naumovski L, Chen C, Fang H, Lai DW et al: First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2021, 27(13):3556-3566.
9. Kobe B, Kajava AV: The leucine-rich repeat as a protein recognition motif. Current opinion in structural biology 2001, 11(6):725-732.
10. Dominguez CX, Müller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, Breart B, Foreman O, Bainbridge TW, Castiglioni A et al: Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy. Cancer discovery 2020, 10(2):232-253.
11. Braun DA, Burke KP, Van Allen EM: Genomic Approaches to Understanding Response and Resistance to Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2016, 22(23):5642-5650.
12. Chen DS, Mellman I: Elements of cancer immunity and the cancer-immune set point. Nature 2017, 541(7637):321-330.
13. Zhang Z, Li H, Jiang S, Li R, Li W, Chen H, Bo X: A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data. Briefings in bioinformatics 2019, 20(4):1524-1541.
14. Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I et al: TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 2016, 44(8):e71.
15. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (New York, NY) 2004, 6(1):1-6.
16. Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S: UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia (New York, NY) 2017, 19(8):649-658.
17. Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z: GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 2017, 45(W1):W98-w102.
18. Nagy Á, Lánczky A, Menyhárt O, Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Scientific reports 2018, 8(1):9227.
19. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A et al: Proteomics. Tissue-based map of the human proteome. Science (New York, NY) 2015, 347(6220):1260419.
20. Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS: TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer research 2017, 77(21):e108-e110.
21. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT et al: The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010, 38(Web Server issue):W214-220.
22. Ben-Ami E, Perret R, Huang Y, Courgeon F, Gokhale PC, Laroche-Clary A, Eschle BK, Velasco V, Le Loarer F, Algeo MP et al: LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications. Cancers 2020, 12(3).
23. Slemmons KK, Mukherjee S, Meltzer P, Purcell JW, Helman LJ: LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies. Pediatric blood & cancer 2021, 68(2):e28771.
24. Hingorani P, Roth ME, Wang Y, Zhang W, Gill JB, Harrison DJ, Teicher B, Erickson S, Gatto G, Smith MA et al: ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium. Molecular cancer therapeutics 2021, 20(3):535-540.
25. Fortis SP, Mahaira LG, Anastasopoulou EA, Voutsas IF, Perez SA, Baxevanis CN: Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model. Cancer immunology, immunotherapy : CII 2017, 66(12):1631-1642.
26. Priedigkeit N, Watters RJ, Lucas PC, Basudan A, Bhargava R, Horne W, Kolls JK, Fang Z, Rosenzweig MQ, Brufsky AM et al: Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight 2017, 2(17).
27. Jia D, Li S, Li D, Xue H, Yang D, Liu Y: Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging 2018, 10(4):592-605.
28. Tang H, Liu W, Xu Z, Zhao J, Wang W, Yu Z, Wei M: Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration. Journal of cellular and molecular medicine 2021, 25(12):5534-5546.
29. Herrera AF, Moskowitz AJ, Bartlett NL, Vose JM, Ramchandren R, Feldman TA, LaCasce AS, Ansell SM, Moskowitz CH, Fenton K et al: Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma. Blood 2018, 131(11):1183-1194.
30. Turley SJ, Cremasco V, Astarita JL: Immunological hallmarks of stromal cells in the tumour microenvironment. Nature reviews Immunology 2015, 15(11):669-682.
31. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D et al: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science (New York, NY) 2009, 324(5933):1457-1461.
32. Wang Y, Liu Y, Zhang M, Lv L, Zhang X, Zhang P, Zhou Y: LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation. Stem cell research & therapy 2018, 9(1):65.